Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2402936
Max Phase: Preclinical
Molecular Formula: C27H34N8O6S
Molecular Weight: 598.69
Molecule Type: Small molecule
Associated Items:
ID: ALA2402936
Max Phase: Preclinical
Molecular Formula: C27H34N8O6S
Molecular Weight: 598.69
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)[C@@H]1CNC(=S)NC[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)C(=O)NCC(=O)N[C@@H](Cc2ccccc2)C(=O)N1
Standard InChI: InChI=1S/C27H34N8O6S/c28-18(10-16-6-8-17(36)9-7-16)24(39)35-21-13-32-27(42)31-12-20(23(29)38)34-26(41)19(11-15-4-2-1-3-5-15)33-22(37)14-30-25(21)40/h1-9,18-21,36H,10-14,28H2,(H2,29,38)(H,30,40)(H,33,37)(H,34,41)(H,35,39)(H2,31,32,42)/t18-,19-,20-,21+/m0/s1
Standard InChI Key: MNTOUKHSDQFMMF-XSDIEEQYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 598.69 | Molecular Weight (Monoisotopic): 598.2322 | AlogP: -2.96 | #Rotatable Bonds: 7 |
Polar Surface Area: 229.80 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.47 | CX Basic pKa: 7.73 | CX LogP: -2.32 | CX LogD: -2.68 |
Aromatic Rings: 2 | Heavy Atoms: 42 | QED Weighted: 0.15 | Np Likeness Score: 0.61 |
1. Touati-Jallabe Y, Bojnik E, Legrand B, Mauchauffée E, Chung NN, Schiller PW, Benyhe S, Averlant-Petit MC, Martinez J, Hernandez JF.. (2013) Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations., 56 (14): [PMID:23822516] [10.1021/jm4008592] |
2. Touati-Jallabe Y, Bojnik E, Legrand B, Mauchauffée E, Chung NN, Schiller PW, Benyhe S, Averlant-Petit MC, Martinez J, Hernandez JF.. (2013) Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations., 56 (14): [PMID:23822516] [10.1021/jm4008592] |
Source(1):